Taking people in FranceNo phase
Studying monocyte cells in people with myeloproliferative neoplasms
Studies how monocytes affect blood stem cell growth in people with myeloproliferative neoplasms.
Key facts
- Who runs it
- University Hospital, Brest
- Where
- Brest, FranceSee the site
- Trial code
- Registry title
- Exploring the Impact of Monocytes in Myeloproliferative Neoplasia (EMYNEM)
- Status
- Recruiting
- People taking part
- 10 people, planned
- Started
- 1 Jun 2024
- Expected to end
- 31 Jan 2028
- Type of study
- Observational
- Record updated
- 17 June 2024
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults who have been diagnosed with a myeloproliferative neoplasm (MPN) at the participating center.
- Age
- Over 18 years old (minimum age 18 Years)
- Sex
- All sexes can join.
- Disease stage
- Diagnosis of MPN (myeloproliferative neoplasm) at the participating center. No specific stage is stated.
Main reasons for not taking part
- People who are not able to consent cannot join.
The registry criteria, word for word
Show all 3 criteriaShow less
Who can take part
- Diagnosis of MPN in the participating center
- Over 18 yo
Who cannot take part
- Not able to consent
Where in France
- Chu BrestBrest, FranceContact: Eric LIPPERTTaking people
About the trial
What the trial wants to find out
Impact of monocytes on Myeloproliferative Neoplasm hematopoietic stem cell growth and differentiation in vitro
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Exploring the Impact of Monocytes in Myeloproliferative Neoplasia
- Plain-language title
- Studying monocyte cells in people with myeloproliferative neoplasmsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 17 June 2024